Protective Factors for Colorectal Cancer

Main Article Content

Gloria Nataly Pérez Serrano
Alejandra Jeraldine Gonzalez Barajas

Abstract

Aspirin and other nonsteroidal anti-inflammatory medicines (NSAIDs) have been shown in a large body of research to be protective against the growth of adenomas and colon cancer. the possible benefit of NSAIDs like aspirin in preventing CRC. Other protective factors have also been found, mostly through observational research, but the potency of some of these correlations is not clear. Dietary regimens of a certain kind may lower the risk of CRC.

Article Details

How to Cite
Serrano, G. N. P., & Barajas, A. J. G. (2022). Protective Factors for Colorectal Cancer. International Journal of Medical Science and Clinical Research Studies, 2(10), 1123–1125. https://doi.org/10.47191/ijmscrs/v2-i10-23
Section
Articles

References

REFERENCES

I. Qadir, M. I., & Ghalia, B. A. (2018). Awareness survey about colorectal cancer in students of M. Phil Biotechnology at Bahauddin Zakariya University, Multan, Pakistan. Nov Appro in Can Study, 1(3).

II. Macrae, F. A., Goldberg, R. M., & Seres, D. (2016). Colorectal cancer: Epidemiology, risk factors, and protective factors. Uptodate com [ažurirano 9. lipnja 2017.

III. Kotzev, I., Mirchev, M., Manevska, B., Ivanova, I., & Kaneva, M. (2008). Risk and protective factors for development of colorectal polyps and cancer. Hepato Gastroenterol, 55, 381-387.

IV. Castro-Rodriguez, J. A., Garcia-Marcos, L., Rojas, J. D. A., Valverde-Molina, J., & Sanchez-Solis, M. (2008). Mediterranean diet as a protective factor for wheezing in preschool children. The Journal of pediatrics, 152(6), 823-828.

V. Segovia-Siapco, G., & Sabaté, J. (2019). Health and sustainability outcomes of vegetarian dietary patterns: a revisit of the EPIC-Oxford and the Adventist Health Study-2 cohorts. European journal of clinical nutrition, 72(1), 60-70.

VI. Park, Y., Hunter, D. J., Spiegelman, D., Bergkvist, L., Berrino, F., Van Den Brandt, P. A., ... & Smith-Warner, S. A. (2005). Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. Jama, 294(22), 2849-2857.

VII. Mathers, J. C., Movahedi, M., Macrae, F., Mecklin, J. P., Moeslein, G., Olschwang, S., ... & CAPP2 Investigators. (2012). Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. The lancet oncology, 13(12), 1242-1249.

VIII. Moazzen, S., Dolatkhah, R., Tabrizi, J. S., Shaarbafi, J., Alizadeh, B. Z., de Bock, G. H., & Dastgiri, S. (2018). Folic acid intake and folate status and colorectal cancer risk: a systematic review and meta-analysis. Clinical nutrition, 37(6), 1926-1934.

IX. Zhang, X. H., Ma, J., Smith-Warner, S. A., Lee, J. E., & Giovannucci, E. (2013). Vitamin B6 and colorectal cancer: current evidence and future directions. World journal of gastroenterology: WJG, 19(7), 1005.

X. Ortega, R. M., Ortega, A. I. J., Sánchez, J. M. P., Soto, E. C., Vizuete, A. A., & López-Sobaler, A. M. (2019). Nutritional value of dairy products and recommended daily consumption. Nutricion hospitalaria, 36(Spec No3), 25-29.

XI. Gorham, E. D., Garland, C. F., Garland, F. C., Grant, W. B., Mohr, S. B., Lipkin, M., ... & Holick, M. F. (2005). Vitamin D and prevention of colorectal cancer. The Journal of steroid biochemistry and molecular biology, 97(1-2), 179-194.

XII. Chen, G. C., Pang, Z., & Liu, Q. F. (2012). Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies. European journal of clinical nutrition, 66(11), 1182-1186.

XIII. Ngo, S. N., Williams, D. B., Cobiac, L., & Head, R. J. (2007). Does garlic reduce risk of colorectal cancer? A systematic review. The Journal of nutrition, 137(10), 2264-2269.

XIV. Wu, S., Feng, B., Li, K., Zhu, X., Liang, S., Liu, X., ... & Fan, D. (2012). Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. The American journal of medicine, 125(6), 551-559.

XV. Schrör, K. (2011). Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best practice & research Clinical gastroenterology, 25(4-5), 473-484.

XVI. La Vecchia, C., Brinton, L. A., & McTiernan, A. (2001). Menopause, hormone replacement therapy and cancer. Maturitas, 39(2), 97-115.

XVII. Bjelakovic, G., Nagorni, A., Nikolova, D., Simonetti, R. G., Bjelakovic, M., & Gluud, C. (2006). Meta‐analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Alimentary pharmacology & therapeutics, 24(2), 281-291.

XVIII. Green, J., Czanner, G., Reeves, G., Watson, J., Wise, L., & Beral, V. (2010). Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. Bmj, 341.

XIX. Ozawa, T., Hashiguchi, Y., Yagi, T., Fukushima, Y., Shimada, R., Hayama, T., ... & Matsuda, K. (2019). Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers. International Journal of Colorectal Disease, 34(10), 1731-1739.

Most read articles by the same author(s)